Mizuho Reiterates Outperform Rating on Encompass Health Corp (EHC)

Mizuho analyst Ann Hynes reiterated an Outperform rating and $134.00 price target on Encompass Health Corp (NYSE: EHC).

The analyst commented: "We held an investor meeting with EHC management including President and CEO Mark Tarr, EVP and CFO Doug Coltharp and, EVP and COO Pat Tuer. The main takeaways from the meeting include: 1) the solid demand appears durable due to the underlying aging of the population, market share gains and capacity expansion, 2) labor and costs trends remain stable to improving, 3) capacity additions continue to be a main focus for capital deployment, and 4) the company appears to have minimal exposure to regulatory and legislative risks at this juncture. Overall, we believe earnings visibility appears high, and we reiterate our Outperform rating and our price target of $134."

For an analyst ratings summary and ratings history on Encompass Health Corp click here. For more ratings news on Encompass Health Corp click here.

Shares of Encompass Health Corp closed at $124.66 yesterday.

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating